Travel medications for OCONUS travelers to include azithromycin, ciprofloxacin, doxycycline, mefloquine, malarone, acetazolamide, tamiflu, lamivudine, acetylzolamide, federal excise tax, product…
Ended Awarded Last action
- Contract number
- 15F06723F0000305
- Awardee
-
A-S Medication Solutions LLC UEI MV3FLB6ATM27
- Awarding agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Obligated
- $206,076
Award facts
- Contract value 29% obligated
-
- $206,075.89 Current, with exercised options
- $706,075.89 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Libertyville, IL 60048, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$43,924 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$50,000 | |
| Original award | $300,000 |
About this award
A-S Medication Solutions LLC, doing business as Allscripts Medication Services Group, was awarded a firm fixed price Blanket Purchase Agreement (BPA) call by the U.S. Department of Justice's Federal Bureau of Investigation (FBI) Headquarters Division. The award, with a ceiling value of $706,075.89 and completion date of September 25, 2023, is for the provision of travel medications for overseas FBI travelers, including drugs such as azithromycin, ciprofloxacin, doxycycline, and malarone. As the FBI conducts global operations, ready access to these medical countermeasures is crucial for the health and safety of personnel representing the United States abroad. This award is not associated with any set-aside designation.
Description
Travel medications for OCONUS travelers to include azithromycin, ciprofloxacin, doxycycline, mefloquine, malarone, acetazolamide, tamiflu, lamivudine, acetylzolamide, federal excise tax, product authentication fee. Other medications as needed based O
Quick answers
Who was awarded contract 15F06723F0000305?
15F06723F0000305 was awarded to A-S Medication Solutions LLC by Headquarters Division (Federal Bureau of Investigation) on February 7, 2023.
How much is contract 15F06723F0000305 worth?
The government has obligated $206,076 on 15F06723F0000305. Its potential value, with all options, is $706,076.
Is contract 15F06723F0000305 an order under another contract?
Yes. 15F06723F0000305 is a BPA call under 15F06722A0001087, a blanket purchase agreement.
Was contract 15F06723F0000305 competed?
The extent of competition for 15F06723F0000305 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award